Till today, the duration of antibiotic therapy for community-acquired pneumonia (EP) remains a subject of debate. In different clinical guidelines the duration of antibiotic administration varies. Meanwhile, there is growing evidence that short-term antibiotic regimens for non-severe respiratory infections of the lower respiratory tract seem attractive and promising
AbstractThere are no studies to guide the optimal duration of therapy in severe community-acquired p...
This is a commentary on the manuscript of Fally et al. focused on the time to first antibiotic dose ...
Background/aim: The optimal empiric antibiotic regimen for patients with community-acquired pneumoni...
Reduction of the inappropriate use of antibiotics in clinical practice is one of the main goals of t...
Recent guidelines suggest that duration of antibiotic therapy for hospitalized patients with communi...
Pneumonia treatment guidelines are recommending shorter courses of antibiotic therapy based on clini...
Purpose of review The appropriate duration of antimicrobial treatment in patients with pneumonia rem...
International experts suggest tailoring antibiotic duration in community-acquired pneumonia (CAP) ac...
Improved access to healthcare, vaccines and treatment with antibiotics has reduced global mortality ...
In 2019, guidelines for the management of immunocompetent adults with community-acquired pneumonia (...
Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality worldwide. Non-compli...
Is 5 days of antibiotic therapy really sufficient for adults hospitalized with community-acquired pn...
Nosocomial pneumonia is the second most frequent nosocomial infection and represents the leading cau...
The increased emphasis on pneumonia-related performance measures and patient outcomes has led hospit...
ObjectivePractice guidelines recommend the shortest duration of antimicrobial therapy appropriate to...
AbstractThere are no studies to guide the optimal duration of therapy in severe community-acquired p...
This is a commentary on the manuscript of Fally et al. focused on the time to first antibiotic dose ...
Background/aim: The optimal empiric antibiotic regimen for patients with community-acquired pneumoni...
Reduction of the inappropriate use of antibiotics in clinical practice is one of the main goals of t...
Recent guidelines suggest that duration of antibiotic therapy for hospitalized patients with communi...
Pneumonia treatment guidelines are recommending shorter courses of antibiotic therapy based on clini...
Purpose of review The appropriate duration of antimicrobial treatment in patients with pneumonia rem...
International experts suggest tailoring antibiotic duration in community-acquired pneumonia (CAP) ac...
Improved access to healthcare, vaccines and treatment with antibiotics has reduced global mortality ...
In 2019, guidelines for the management of immunocompetent adults with community-acquired pneumonia (...
Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality worldwide. Non-compli...
Is 5 days of antibiotic therapy really sufficient for adults hospitalized with community-acquired pn...
Nosocomial pneumonia is the second most frequent nosocomial infection and represents the leading cau...
The increased emphasis on pneumonia-related performance measures and patient outcomes has led hospit...
ObjectivePractice guidelines recommend the shortest duration of antimicrobial therapy appropriate to...
AbstractThere are no studies to guide the optimal duration of therapy in severe community-acquired p...
This is a commentary on the manuscript of Fally et al. focused on the time to first antibiotic dose ...
Background/aim: The optimal empiric antibiotic regimen for patients with community-acquired pneumoni...